B‐cell maturation antigen chimeric antigen receptor‐T therapy alleviated heart failure in patients with multiple myeloma

B‐cell maturation antigen chimeric antigen receptor‐T therapy alleviated heart failure in patients with multiple myeloma

Abstract Patients with multiple myeloma (MM) are likely to achieve poor therapeutic response when organs are involved. We produced anti‐B‐cell maturation antigen (BCMA) chimeric antigen receptor (CAR)‐T cells, which are in a trial for patients with relapsed/refractory MM. One enrolled patient develo...

Full description

Bibliographic Details
Main Authors: Yunhong Wang, Ke Zhang, Xiaohui Suo, Ning Meng, Yuanrui Gu, Yilang Qin, Yanxia Tu, Xiaohui Zhang, Guofeng Sun, Jiaojiao Ji, Weichun Wu, Yuqi Cai, Kai Yang, Chenxi Ouyang, Junyuan Qi
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:ESC Heart Failure
Subjects:
Anti‐B‐cell maturation antigen
Chimeric antigen receptor‐modified T cells
Light chain cardiac amyloidosis
Multiple myeloma
Online Access:https://doi.org/10.1002/ehf2.14554

Internet

https://doi.org/10.1002/ehf2.14554

Similar Items